Add BrightSurf on Google Email

Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

A study at ESMO World Congress on Gastrointestinal Cancer 2019 found that a more flexible dosing regimen for regorafenib improves patients' quality of life while maintaining its efficacy. The reduced and intermittent dose groups showed numerical improvements in tolerance to side effects such as fatigue and hand-foot syndrome.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·DateJul 6, 2019

Identifying colorectal cancer subtypes could lead to improved treatment decisions

Researchers found that identifying a patient's Consensus Molecular Subtype (CMS) could help oncologists determine the most effective course of treatment. CMS categorizes colorectal cancer into four distinct subgroups based on tumor mutations, and each subgroup is associated with different treatment outcomes.

SourceUniversity of Southern California - Health Sciences·JournalJournal of Clinical Oncology·DateJun 12, 2019

The Lancet Gastroenterology & Hepatology: Colorectal cancer incidence on the rise among young adults in several high-income countries

The study found significant increases in colon and rectal cancer incidence among young adults in several high-income countries, including Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the UK. The incidence of colon cancer increased significantly each year in people aged 0-49 years, while rectal cancer incidence was most...

SourceThe Lancet·JournalThe Lancet Gastroenterology & Hepatology·DateMay 16, 2019

Mailing colorectal cancer screening kit found effective, regardless of financial incentive

Researchers found that mailing FIT kits directly to patients increased completion rates by 24-29% within two-six months. Financial incentives did not significantly improve results. The study suggests framing and context of incentives can be more important than their dollar value, highlighting the principles of behavioral economics.

SourceUniversity of Pennsylvania School of Medicine·JournalJAMA Network Open·DateMar 22, 2019

Consuming garlic and onions may lower colorectal cancer risk

Consuming garlic and onions has been shown to lower the risk of colorectal cancer in a Chinese study involving 833 patients. Adults who ate high amounts of allium vegetables had an 79% lower chance of developing the disease compared to those who consumed low amounts.

SourceWiley·JournalAsia-Pacific Journal of Clinical Oncology·DateFeb 21, 2019

Patients who identify as transgender have lower odds of being screened for cancer: Study

A study at St. Michael's Hospital found that transgender patients have lower odds of being screened for certain types of cancer, including breast, cervical, and colorectal cancer. Transgender patients had a 70% lower odds of being screened for breast cancer, with similar disparities seen in cervical and colorectal cancer screening.

SourceSt. Michael's Hospital·JournalCanadian Family Physician·DateJan 23, 2019

The Lancet: High intake of dietary fiber and whole grains associated with reduced risk of non-communicable diseases

A study published in The Lancet reveals that consuming at least 25g to 29g of dietary fibre per day can reduce the risk of non-communicable diseases such as coronary heart disease, stroke, type 2 diabetes, and colorectal cancer by 16-24%. Whole grains also show promise in reducing mortality rates and incidence of these diseases.

SourceThe Lancet·JournalThe Lancet·DateJan 10, 2019

Does work stress increase cancer risk?

A study of over 280,000 people found a significant association between work stress and increased risk of colorectal and esophagus cancers. However, no link was observed for prostate, breast, or ovarian cancers, with the relationship varying by region.

SourceWiley·JournalInternational Journal of Cancer·DateDec 12, 2018

Many patients diagnosed with adenomas may not receive colonoscopies in recommended time frame

A recent study published in Cancer Epidemiology, Biomarkers & Prevention found that many patients diagnosed with adenomas often do not receive subsequent colonoscopies within the recommended time frame. The study analyzed patterns and factors associated with the receipt of colonoscopy within approximately three years of a diagnosis of ...